Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.

Slides:

Advertisements

Similar presentations

Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma Kazuya Takamochi, MD, Shiaki Oh, MD,

Advertisements

Elizabeth A. David, MD, David T

Left Video-Assisted Thoracoscopic Surgery Esophagectomy in a Patient With Situs Inversus Totalis and Kartagener Syndrome John Peel, BHSc, Gail Darling,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations Tae Jung Kim, MD, PhD, Choon-Taek.

Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non- Small Cell Lung Cancer Ken Kodama, MD, Masahiko Higashiyama, MD, Jiro.

Joshua E. Rosen, BASc, Hari B

Long Interspersed Nucleotide Element 1 Hypomethylation Is Associated With Poor Prognosis of Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi,

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201 Hisao Asamura, MD, Tomoyuki.

Study on Perioperative Administration of a Neutrophil Elastase Inhibitor for Interstitial Pneumonias Mariko Fukui, PhD, Kazuya Takamochi, PhD, Shiaki.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Andranik Petrosyan, MD, Patrice Bergeron, MD

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Utility of Objective Chest Tube Management After Pulmonary Resection Using a Digital Drainage System Kazuya Takamochi, MD, Kota Imashimizu, MD, Mariko.

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.

Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography:

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Tracheostomy After Cardiac Operations: In-Hospital and Long-Term Survival Andrea Ballotta, MD, Hassan Kandil, MD, Tommaso Generali, MD, Lorenzo Menicanti,

Surgical Resection of a Giant Coronary Aneurysm

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Katy A. Marino, MD, Jennifer L. Sullivan, MD, Benny Weksler, MD

Surgical Treatments for Multiple Primary Adenocarcinoma of the Lung

Samuel P. Morreau, David A. Haydock, MBChB, FRACS

Clinicopathologic Features of Resected Subcentimeter Lung Cancer

Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non–Small Cell Lung Cancer Aritoshi Hattori, MD,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions Hisao Asamura, MD, Kenji Suzuki,

Radiologic Classification of Small Adenocarcinoma of the Lung: Radiologic-Pathologic Correlation and Its Prognostic Impact Kenji Suzuki, MD, Masahiko.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Pulmonary Resection for Lung Cancer in Octogenarians

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Differentiating N0 Versus N1 Lung Cancer Kazuhiro Yasufuku, MD, PhD, Takahiro Nakajima,

New Technique for Lung Segmentectomy Using Indocyanine Green Injection

Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung Yukio Watanabe, MD, Koji.

Extensive Invasion of the Left Atrium by Lung Cancer

“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin- section computed tomographic scan Kenji Suzuki, MD, Hisao Asamura,

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi, MD, PhD,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Mediastinal Paragangliomas: The Mayo Clinic Experience

Aritoshi Hattori, MD, Kenji Suzuki, MD

Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma Hirofumi Uehara, MD,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter Norihiko Ikeda, MD, PhD, Junichi Maeda, MD, Koichi Yashima, MD, Masahiro.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi.

Radical Carinal Resection for a Glomic Tumor

Presentation transcript:

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya Takamochi, MD, Shiaki Oh, MD, Kenji Suzuki, MD The Annals of Thoracic Surgery Volume 102, Issue 2, Pages 407-415 (August 2016) DOI: 10.1016/j.athoracsur.2016.02.074 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Radiologic classification of 1,181 patients with surgically resected c-N0 M0 NSCLC of any T grade based on the findings on thin-section computed tomography (CT) scan. (CTR = consolidation tumor ratio; GGO = ground-glass opacity.) The Annals of Thoracic Surgery 2016 102, 407-415DOI: (10.1016/j.athoracsur.2016.02.074) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall survival curves of 565 patients with clinical N0 M0 radiologically solid lung cancers are presented based on tumor size: ≤20 mm (blue line); 21–30 mm (green line); 31–50 mm (gray line); and ≥51 mm (purple line). The Annals of Thoracic Surgery 2016 102, 407-415DOI: (10.1016/j.athoracsur.2016.02.074) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Overall survival curves of 448 patients with clinical N0 M0 radiologically part-solid lung cancers are presented based on tumor size (A: ≤20 mm [blue line]; 21–30 mm [green line]; and ≥31 mm [gray line]) or consolidation tumor ratio (B: 0 < CTR ≤ 0.50 [blue line]; 0.50 < CTR < 1.0 [green line]). The Annals of Thoracic Surgery 2016 102, 407-415DOI: (10.1016/j.athoracsur.2016.02.074) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions